The REMEEX® system for the treatment of male SUI presents (in our experience) a 75% of good results (continent patients or patients with light urinary incontinence) at the year of follow-up with a high rate of light complications. Readjustment are frequent at the first six months after intervention and it's necessary an intense follow-up. We need more studies that evaluate the long-term efficiency of this system.
BackgroundBenign prostatic hyperplasia (BPH) is a prevalent disease associated with lower urinary tract symptoms (LUTS). The standard of care for moderate-to-severe LUTS unresponsive to pharmacological treatment is the transurethral resection of the prostate (TURP). However, this intervention is not exempt from complications. Prostatic artery embolization (PAE) has been described as a new, effective and safe procedure for the treatment of LUTS secondary to BPH. To date, only one clinical trial has been published on the use of PAE for LUTS, but the study was methodologically flawed in terms of safety monitoring. Therefore, well-designed clinical studies are required to compare the efficacy and safety of both techniques in the treatment of LUTS secondary to BPH.Methods and designThis was a prospective, randomized, non-inferiority clinical trial comparing efficacy and safety of PAE and TURP in the treatment of BPH-related LUTS. A total of 60 patients diagnosed with BPH with obstructive moderate or severe LUTS refractory to medical therapy and candidates for TURP were randomized to either PAE or TURP. The presence and severity of LUTS were assessed using the validated Spanish version of the International Prostate Symptom Score (IPSS). Primary end points included improvement in maximum urinary flow rate (Qmax) as measured at baseline and 1 year after the intervention. Improvement in IPSS as measured at baseline and after the intervention, reduction in prostate volume, no deterioration or improvement of sexual function (International Index of Erectile Function [IIEF]), reduction in PSA and PVR, satisfaction of the patient with the operation and adverse events occurring during the study were secondary outcome measures.DiscussionThe aim of this clinical study was to investigate whether PAE is a valid therapeutic option for LUTS that is not inferior to TURP in terms of efficacy and safety. This study also helped to define the profile of candidates for PAE and analyzed the benefits and complications associated with this new technique.
Kaposi sarcoma is an angioproliferative disorder that ranges from a single indolent skin lesion to respiratory and gastrointestinal/visceral involvement. Kaposi sarcoma is rare in non-immunosuppressed patients. Nineteen cases of penile Kaposi sarcoma in HIV-negative patients were reported in 2012. We present the case report of a 48-year-old male patient with no previous medical history, who came to our urology clinic presenting a purple-color papule on the penis glans. Lab tests revealed negative serology for HIV, but tissue PCR was positive for human herpesvirus 8. Histopathology examination after lesion excision was compatible with Kaposi sarcoma. No other cutaneous or mucosal lesions were present. Primary Kaposi sarcoma of the penis is rare, but may occur in non-immunosuppressed patients.
Introducción: En el año 2004 iniciamos la técnica de TOT para el tratamiento de la incontinencia urinaria de esfuerzo. En este estudio comparamos los resultados con las series publicadas de TOT y con la serie de TVT realizadas en nuestro servicio.Material y métodos: Hemos intervenido a 171 pacientes, con una edad media de 57,7 años. En el 167% de ellas, además de realizar TOT, asociamos reparación de defectos anatómicos pélvicos.Resultados: Con un seguimiento medio de 12 meses y mediana de 14 meses, el 87% de las pacientes están curadas. Los fracasos aparecieron de forma precoz en los 3 primeros meses de seguimiento. Como complicaciones aparecieron, retenciones post-operatorias de menos de 30 días en el 2,7%, retenciones a largo en el 4,8%, hematomas post-quirúrgicos en el 1,3%, extrusión de la malla en el 2% y urgencia de novo en el 2.3%. Conclusiones: La TOT es una técnica no exenta de complicaciones aunque la proporción de ellas es baja y con unos resultados que son alentadores. Se trata de una técnica quirúrgica sencilla, que como toda técnica, tiene una curva de aprendizaje. Requiere un corto tiempo quirúrgico (menor que la TVT) y puede ser realizada en régimen de Cirugía Mayor Ambulatoria. Las dos técnicas (TVT/TOT) han demostrado ser similares en cuanto a tasas de curación aunque en la serie de TOT es levemente más baja. Las diferencias de las complicaciones se dan en los porcentajes aunque siempre escasas.Palabras clave: TVT. TOT. Incontinencia de esfuerzo. ABSTRACT TOT IN THE TREATMENT OF THE STRESS URINARY INCONTINENCE: OUR EXPERIENCE,COMPARING IT WITH THE TVT Introduction: In the year 2004 begin the technique of TOT for the treatment of the urinary incontinence of effort. In this study we compare the results with the published series of TOT and with the series of TVT carried out in our service.Material and methods: We have intervened to 171 patients, with a 57.7 year-old half age. In their 16%, besides carrying out TOT, we associate repair of anatomical pelvic defects.Results: After a follow-up of 12 months and a mean of 14, 87% of the cases succeeded. Failures arose during the first three months of therapy. As complications they appeared post-operative retentions of less than 30 days in 2.7%, retentions to long in 4.8%, post-surgical hematomas in 1.3%, extrusion of the mesh in 2% and novo urgency in 2.3%.Conclusions: TOT is a technique it doesn't exempt of complications although their proportion is low and with some results that they are encouraging. It is about a surgical simple technique that as all technique, he/she has a learning curve. It requires a surgical (smaller than TVT) short time and it can be carried out in régime of bigger Ambulatory Surgery. The two techniques (TVT / TOT) have demonstrated to be similar as for cure rates although in the series of TOT it is slightly more baja. Las differences of the complications they are given in the percentages although always scarce.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.